Published in:
Open Access
01-12-2023 | Computed Tomography | Research
The role of computed tomography features in assessing response to neoadjuvant chemotherapy in locally advanced gastric cancer
Authors:
Chengzhi Wei, Yun He, Ma Luo, Guoming Chen, Runcong Nie, Xiaojiang Chen, Zhiwei Zhou, Yongming Chen
Published in:
BMC Cancer
|
Issue 1/2023
Login to get access
Abstract
Objective
To compare the computed tomography (CT) images of patients with locally advanced gastric cancer (GC) before and after neoadjuvant chemotherapy (NAC) in order to identify CT features that could predict pathological response to NAC.
Methods
We included patients with locally advanced GC who underwent gastrectomy after NAC from September 2016 to September 2021. We retrieved and collected the patients’ clinicopathological characteristics and CT images before and after NAC. We analyzed CT features that could differentiate responders from non-responders and established a logistic regression equation based on these features.
Results
We included 97 patients (69 [71.1%] men; median [range] age, 60 [26–75] years) in this study, including 66 (68.0%) responders and 31 (32.0%) non-responders. No clinicopathological variable prior to treatment was significantly associated with pathological response. Out of 16 features, three features (ratio of tumor thickness reduction, ratio of reduction of primary tumor attenuation in arterial phase, and ratio of reduction of largest lymph node attenuation in venous phase) on logistic regression analysis were used to establish a regression equation that demonstrated good discrimination performance in predicting pathological response (area under receiver operating characteristic curve 0.955; 95% CI, 0.911–0.998).
Conclusion
Logistic regression equation based on three CT features can help predict the pathological response of patients with locally advanced GC to NAC.